Renalytix Ai Rg

Renalytix Plc offers AI‑driven KidneyIntelX, a biomarker‑based diagnostic platform for early kidney disease risk scoring, used in clinical care, trials and drug discovery. Partnerships with top U.S. health systems support market expansion.

Headquarters: United Kingdom (GBR)

Renalytix Ai Rg Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
RENX Renalytix Ai Rg
Cap: 0.0B
EQUITY LSE GBP GB00BYWL4Y04 Active
📈
Home Login